Results 281 to 290 of about 73,607 (303)

[JAK2, CALR].

Rinsho byori. The Japanese journal of clinical pathology, 2019
Representative diseases of BCR/ABL-negative myeloproliferative neoplasms (MPN) are polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). It was reported in 2005 that there is a common genetic mutation in Exon 14 of the JAK2 gene in MPN cases.
openaire   +1 more source

?????????????? V617F ???????? jak2 ???? ??????????????????????-???????????????????? ???????????? ?? ???????????? ???? ???????????????? ?????????????????????????????????????? ????????????????????????

2021
V617F mutation jak2 gene is an important diagnostic criterion for the diagnosis of chronic myeloproliferative disorders. The method of detection using RT-PCR and direct sequencing was propoused.
openaire   +1 more source

Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria

Cell, 2023
Jonathan Bohlen, Clement Conil, Eeva Salo   +2 more
exaly  

???????????????????????? ???????????????? ?????????????????????????? ?????????????????????? ???????????????????? ?????????????????????? ?? ?????????????????? ?????????????????????????? ???? ???? ??????????????? ???? ?????????????????? ?????????????? JAK2 V617F

2018
????????: ?????????????????????? ???????????????? ?????????????????????????? ?????????? ???????????????????? ?????????????????????? (????) ???? ?????????????????? ?????????????????????????? (????), ???????????? ???? ??????????????? ?? ?????????????????? ?????????????? JAK2 V617F, ???????????????????? ???????????????????? ???? ??????????????????????????
openaire   +1 more source

Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review

Journal of Inflammation Research, 2022
Teklie Mengie Ayele, Zelalem Tilahun Muche, Awgichew Behaile Teklemariam   +2 more
exaly  

The role of IL-6/JAK2/STAT3 signaling pathway in cancers

Frontiers in Oncology, 2022
Bei Huang
exaly  

???????????????? ????????-?????????????? ?????? ?????????????????? ?????????????? V617F ???????? jak2 ?? ???????????? ???? ???????????????? ?????????????????????????????????????? ????????????????????????

2011
?????????????? V617F ???????? jak2 ???????????????? ???????????? ?????????????????????????????? ?????????????????? ?????? ?????????????????????? ???????????????????????????????????????? ????????????????????????. ???????????????????? ????????-?????????????? ?????? ?????????????????? ?????????????? ?? ?????????????? ???????????? ??????????????-???????????
openaire   +1 more source

JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway

International Immunopharmacology, 2023
Yaru Lu, Hao Ran, Weibin Liu
exaly  

Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation

Cells, 2019
Florian Perner, Caroline Perner, Thomas Ernst   +2 more
exaly  

JAK2

2008
openaire   +1 more source